Valsartan clinical trials
Also written Diovan and VAL489.
Counted the way a researcher would: Valsartan with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.
This browser remembers your choice.
How each study uses Valsartan is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Valsartan studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 23 Dec 1996 · DIOVAN · NDA 020665 (FDA, Drugs@FDA)
- European Union
- 15 Jan 2007 · Copalia · EMEA/H/C/000774 (EMA; in a combination)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
252 studies that test it; most in 2004 (29)
| Year | Studies |
|---|---|
| 2001 | 1 |
| 2002 | 9 |
| 2003 | 13 |
| 2004 | 29 |
| 2005 | 16 |
| 2006 | 27 |
| 2007 | 20 |
| 2008 | 10 |
| 2009 | 10 |
| 2010 | 6 |
| 2011 | 8 |
| 2012 | 8 |
| 2013 | 7 |
| 2014 | 7 |
| 2015 | 3 |
| 2016 | 6 |
| 2017 | 8 |
| 2018 | 9 |
| 2019 | 8 |
| 2020 | 9 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 6 |
| 2024 | 4 |
| 2025 | 7 |
| 2026 | 7 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 137 · Other 117
Novartis (75) · Novartis Pharmaceuticals (28) · Damanhour University (4) · Boehringer Ingelheim (4) · Mario Negri Institute for Pharmacological Research (3) · LG Life Sciences (3) · State University of New York at Buffalo (2) · Ruijin Hospital (2)
Often tested with
Tested in the same studies.
Amlodipine (45) · Sacubitril (44) · Hydrochlorothiazide (34) · Aliskiren (8) · Sacubitril valsartan sodium hydrate (7) · Sacubitril valsartan (7) · Lisinopril (7) · Benazepril (6)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 3 phase 3 studies under way
Valsartan is the comparator. A study of two new drugs counts under both.
- 1Sacubitril valsartan · University of Alabama at Birmingham · next primary completion Jan 2027
Reaching primary completion within a year · 5, 1 in phase 3
Studies that test Valsartan, phase 3 first.
- Apr 2027Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection FractionPhase 3 · Puerta de Hierro University Hospital
- Dec 2026Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery DiseasePhase 4 · China National Center for Cardiovascular Diseases
- Apr 2027Enhancing the Natriuretic Peptide System in HFpEFPhase 1/2 · Horng Chen
- Jul 2027Repurposing Valsartan May Protect Against Pulmonary HypertensionPhase 2 · University of Washington
- Sep 2027TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin TherapyPhase 2 · Myopharm Limited
Studies
Open first, then newest update. How each study uses Valsartan is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 254
- Enhancing the Natriuretic Peptide System in HFpEFEnrolling by invitationPhase 1/2Horng ChenNCT05279742Written as Sacubitril/Valsartan
- Sacubitril/Valsartan vs Standard Treatment for Preventing Atrial Fibrillation Recurrence After Catheter Ablation in Persistent Atrial Fibrillation Patients With Without HypertensionNot yet recruitingPhase 4Ruijin HospitalNCT07910058Written as Sacubitril/Valsartan
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationPhase 4Baylor Research InstituteNCT07547878Written as Diovan
- Manganese-enhanced Magnetic Resonance Imaging in Takotsubo CardiomyopathyRecruitingNot applicableUniversity of EdinburghNCT07491718Written as Valsartan
- Effects of VALsartan On atRIAl Mitral Regurgitation (VALORIA) - PilotRecruitingPhase 2/3Jonathan BeaudoinNCT07539298Written as Valsartan
- The Effect of Sacubitril/Valsartan Versus Ramipril on Left Ventricular Function and Remodeling in Patients With Ischemic Heart Failure With Mid-range Ejection FractionRecruitingPhase 3John Paul II Hospital, KrakowNCT05508035Written as Sacubitril / Valsartan
- TriGlytza®-01 Versus Metformin in Overweight and Obese Adults With Type 2 Diabetes and Inadequate Glycaemic Control Despite Metformin TherapyNot yet recruitingPhase 2Myopharm LimitedNCT07139405Written as Valsartan
- Treating Heart Dysfunction Related to Cancer Therapy With Sacubitril/ValsartanRecruitingPhase 1/2Virginia Commonwealth UniversityNCT05194111Written as Valsartan
- Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural TanzaniaRecruitingPhase 4Martin RohacekNCT06704633Written as Sacubitril / Valsartan Oral Tablet
- Repurposing Valsartan May Protect Against Pulmonary HypertensionRecruitingPhase 2University of WashingtonNCT06053580Written as Valsartan 40 mg
- A Drug-Drug Interaction Study of HDM1002 and Metformin, Empagliflozin, Midazolam, Valsartan, and WarfarinRecruitingPhase 1Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.NCT07331389Written as Valsartan
- Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection FractionRecruitingNot applicableKafrelsheikh UniversityNCT07192341Written as Sacubitril/Valsartan
- Treatment of Moderate Ischemic Mitral Regurgitation in Patients With Coronary Artery DiseaseRecruitingPhase 4China National Center for Cardiovascular DiseasesNCT06917664Written as sacubitril/valsartan
- A Phase III Clinical Study of Valsartan Oral Solution for the Treatment of Hypertension in Children and AdolescentsEnrolling by invitationPhase 3Shandong New Time Pharmaceutical Co., LTDNCT06863987Written as Valsartan Oral Solution
- Effect of Angiotensin Receptor/Neprilysin Inhibitors on Transthyretin Cardiac Amyloidosis and Heart Failure with Reduced Ejection FractionNot yet recruitingPhase 3Puerta de Hierro University HospitalNCT06712030Written as Sacubitril / Valsartan
- Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic NephropathyNot yet recruitingPhase 4Sichuan Academy of Medical SciencesNCT06501651Written as Sacubitril/Valsartan
- Diuretics vs. Afterload Reduction for Treatment of HeartLogic AlertsRecruitingPhase 4Heart Center Research, LLCNCT06218199Written as sacubitril/valsartan
- Determination of Drug Levels for Pharmacotherapy of Heart FailureNot yet recruitingPhase 4University Hospital OstravaNCT06035978Written as Valsartan and Sacubitril
- Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated TabletsNot yet recruitingPhase 1International Bio serviceNCT06193044Written as Amlodipine/Valsartan
- The Effects of Sacubitril-Valsartan vs Enalapril on Left Ventricular Remodeling in ST-elevation Myocardial InfarctionNot yet recruitingPhase 3West China HospitalNCT04912167Written as Valsartan
See all 254 studies that test Valsartan →
Given beside what is tested · 20 — Valsartan is usual care or a partner of the new treatment
- Delayed Initiation of ARNI and SGLT2i in Heart Failure With Corrected Aetiology (DELAY-HF), Pilot StudyRecruitingPhase 4Kyungsub SongNCT07572032Written as Sacubitril / Valsartan
- Vericiguat in Decompensated Cardiac Failure: Clinical Insights on Addition to Guidelines Derived Medical Therapy-VERCIG TrialRecruitingPhase 1Khawaja Danish AliNCT07444398Written as Sacubitril / Valsartan
- A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive PatientsNot yet recruitingPhase 3CSPC ZhongQi Pharmaceutical Technology Co., Ltd.NCT06771245Written as Valsartan
- Clinical Study to Evaluate the Possible Efficacy and Safety of Levocetirizine in Patients With Diabetic Kidney DiseaseCompletedPhase 2Mostafa BahaaNCT05638880Written as Valsartan 80 mg
- A Study to Evaluate the Effect of Sodium Zirconium Cyclosilicate on Chronic Kidney Disease (CKD) Progression in Participants With CKD and Hyperkalaemia or at Risk of HyperkalaemiaTerminatedPhase 3AstraZenecaNCT05056727Written as Valsartan
- Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1TerminatedPhase 4Vanderbilt University Medical CenterNCT03738878Written as Valsartan
- Effect of HMP on Diabetic Microangiopaemia in T2DMCompletedPhase 4Affiliated Hospital of Nantong UniversityNCT05095922Written as Valsartan Capsules
- Multimodal Analgesia for CholecystectomyCompletedPhase 3Gangnam Severance HospitalNCT04788654Written as Celebrex, acetaminophen, and dexamethasone
- Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MICompletedPhase 3Novartis PharmaceuticalsNCT02924727Written as Valsartan
- Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection?TerminatedPhase 3University of British ColumbiaNCT04606563Written as Valsartan
- Hydroxychloroquine Sulfate Alleviates Persistent Proteinuria in IgA NephropathyStatus unknownPhase 4Peking Union Medical College HospitalNCT02765594Written as Valsartan
- Oral Pharmacokinetics of Sulfasalazine, Paracetamol, Fexofenadine and Valsartan Using Different Administration MediumsCompletedPhase 1University Medicine GreifswaldNCT03012763Written as Valsartan
- Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes NephropathyStatus unknownNot applicableGuangdong Provincial People's HospitalNCT00655330Written as Valsartan
- Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy VolunteersCompletedPhase 2Novartis PharmaceuticalsNCT01353508Written as Valsartan
- Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive HypertensionCompletedPhase 2Novartis PharmaceuticalsNCT01681576Written as Valsartan
- A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA NephropathyCompletedPhase 4Guangdong Provincial People's HospitalNCT00426348Written as Valsartan
- Left Ventricular Hypertrophy Reduction With Statins in Hypertensives Patients (MK0653A-168)TerminatedPhase 3Fundación Lindavista del Corazón ACNCT00738972Written as valsartan
- Effects of Combination Therapy With Alpha-1 Blocker (Bunazosin or Doxazosin) in the Treatment of Patients With Mild to Moderate Essential HypertensionCompletedPhase 4Eisai Inc.NCT00130156Written as Valsartin
- Aliskiren and Valsartan vs Valsartan Alone in Patients With Stage II Systolic Hypertension and Type II Diabetes MellitusCompletedPhase 4NovartisNCT00927394Written as Valsartan
- Controlled Release Nifedipine and Valsartan Combination Therapy in Patients With Essential HypertensionCompletedPhase 4BayerNCT01518855Written as Diovan
As the comparator · 46 — what is tested is compared with Valsartan
- NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health in Black IndividualsRecruitingPhase 2University of Alabama at BirminghamNCT04055428Written as Valsartan 160 mg
- PRECISION-BP: Precision Chronopharamacotherapy Targeting NP-RAAS-BP Rhythm AxisRecruitingPhase 2/3University of Alabama at BirminghamNCT04971720Written as Valsartan 80 mg Oral Tablet
- Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202ARecruitingPhase 3Chong Kun Dang PharmaceuticalNCT06643819Written as Valsartan
- QR12000 Compound Tablets in Patients with Moderate to Severe Essential HypertensionNot yet recruitingPhase 3Wuhan Createrna Science and Technology Co., LtdNCT06716970Written as Sacubitril/valsartan 200mg
- Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3RecruitingPhase 4The First Affiliated Hospital of Dalian Medical UniversityNCT04263922Written as Valsartan capsule
- Neprilysin Inhibition to Reduce Myocardial Fibrosis in Heart Failure With Preserved Ejection FractionWithdrawnPhase 4Brigham and Women's HospitalNCT06536309Written as Valsartan
- A Phase II Clinical Study of QR12000 Compound Tablets in Patients With Moderate to Severe Essential HypertensionCompletedPhase 2Wuhan Createrna Science and Technology Co., LtdNCT07700875Written as Sacubitril / valsartan 200 mg
- Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial FibrillationCompletedPhase 4Shanghai Jiao Tong University School of MedicineNCT05528419Written as Valsartan
- A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart FailureTerminatedPhase 2Novartis PharmaceuticalsNCT06142383Written as Sacubitril/valsartan
- To Evaluate the Safety and PK Characteristics in Healthy Volunteers-LivalozetCompletedPhase 1JW PharmaceuticalNCT01764178Written as Pitavastatin, Valsartan
- The Renin-Angiotensin-Aldosterone System in Adiposity, Blood Pressure and Glucose in African AmericansActive, not recruitingPhase 4Ohio State UniversityNCT03938389Written as Valsartan 160mg
- Role of ARNi in Ventricular Remodeling in Hypertensive LVHCompletedPhase 2National Heart Centre SingaporeNCT03553810Written as Valsartan
- LCZ696 in Advanced LV Hypertrophy and HFpEFCompletedPhase 2National Medical Research Center for Cardiology, Ministry of Health of Russian FederationNCT03928158Written as Valsartan
- Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection FractionCompletedPhase 3Novartis PharmaceuticalsNCT02884206Written as Valsartan
- Valsartan and Amlodipine in Blood Pressure Management: Fixed-Dose vs. Free Drug TherapyCompletedPhase 4Shiraz University of Medical SciencesNCT06487949Written as valsartan 80 mg and amlodipine 5 mg as free combination
- The Effects of Sacubitril/Valsartan on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Heart Failure PatientsCompletedPhase 4Novartis PharmaceuticalsNCT03300427Written as valsartan
- The Bio-Clinical Effects of the (Sacubitril-Valsartan) Combination on Patients With Chronic Heart FailureCompletedPhase 4Amir SafwatNCT04688294Written as Valsartan
- Sacubitril/Valsartan Versus Valsartan for Hypertensive Patients With Acute Myocardial InfarctionStatus unknownPhase 4Qingdao Central HospitalNCT05060588Written as Valsartan 80mg/Tab
- Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvationStatus unknownPhase 2Mark LedwidgeNCT04687111Written as Valsartan
- Efficacy and Safety of Sacubitril/Valsartan in Maintenance Hemodialysis Patients With Heart FailureStatus unknownNot applicableGuangdong Provincial People's HospitalNCT04458285Written as Valsartan 80mg Tablet
Showing 20 of 46.
What changed recently
From the registry's own updates since Oct 18, 2026.
Codes
What other systems call Valsartan · ClinicalTrials.gg INT006536
- MeSH (NLM) D000068756ValsartanConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 80M03YXJ7IVALSARTANConfirmed FDA, NLM, Wikidata
- RxNorm 69749Confirmed FDA, Wikidata
- Wikidata Q155472valsartanConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47781ValsartanOne source FDA
- DrugBank DB00177One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000068756 | Valsartan | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 80M03YXJ7I | VALSARTAN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 69749 | — | Confirmed FDA, Wikidata |
| Wikidata | Q155472 | valsartan | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47781 | Valsartan | One source FDA |
| DrugBank | DB00177 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.